Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells

Pedram Kharaziha(Karolinska University Hospital), Theocharis Panaretakis(Karolinska Institutet)
Cell Death and Disease
January 26, 2012
Cited by 58


Related Papers